A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fisher Wallace Laboratories
With
Advarra
Florence Healthcare
This is a randomized waitlist-controlled trial to evaluate the efficacy and safety of the Fisher Wallace Stimulator FW-200 device in the treatment of self-reported anxiety in police personnel and first responders. Participants will be randomly assigned to receive immediate treatment or deferred treatment with the FW-200 device.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Age 18 years and older
Ability to read and write in English
First responder employee or employee of participating police department
Beck Anxiety Inventory total score above 7
Able to commit to two 20-minute device treatment session per day for up to 8 weeks
Willing to wear an actigraphy device
You may not be if
Use of brain stimulation device in the last year
Have a pacemaker, electronic stent or electronic implants
Started or planning to start new medial treatment or health program over the next 8 weeks
Contemplated suicide in the past year
Institutionalized for mental health issues
Have a serious medical condition
Currently taking medications affecting the nervous system
Allergic to nickel
Currently taking or planning to take part in any other study on insomnia, anxiety or other mental health effort over the next 8 weeks
Currently pregnant or planning to become pregnant in the next 10 weeks
Clareo Health | A Study Comparing Immediate Treatment to Deferred Treatment With the Fisher Wallace (FW) Stimulator FW-200 Device for the Treatment of Self-reported Anxiety in First Responders
